“The Short-Term Efficacy of a Monoclonal Antibody Fragment (brolucizumab) for Treating Neovascular Age-Related Macular Degeneration”. Ukrainian Journal of Ophthalmology , no. 3, July 2024, pp. 28-32, https://doi.org/10.31288/oftalmolzh202432832.